Open AccessPossibly enhanced Gd excretion in dialysate, but no major clinical benefit of 3-5 months of treatment with sodium thiosulfate in late stages of nephrogenic systemic fibrosis
Author(s) -
Peter Marckmann,
Anne Højager Nielsen,
Jens J. Sloth
Publication year - 2008
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfn217
Subject(s) - medicine , nephrogenic systemic fibrosis , sodium thiosulfate , thiosulfate , excretion , fibrosis , sodium , gastroenterology , kidney disease , urology , inorganic chemistry , metallurgy , chemistry , sulfur , materials science
Gd-related nephrogenic systemic fibrosis was successfully treated with intravenous sodium thiosulfate according to a recent case report.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom